Low-Grade Ovarian Serous Neoplasms (Low-Grade Serous Carcinoma and Serous Borderline Tumor) Associated With High-Grade Serous Carcinoma or Undifferentiated Carcinoma
- 1 March 2012
- journal article
- research article
- Published by Wolters Kluwer Health in American Journal of Surgical Pathology
- Vol. 36 (3) , 368-375
Abstract
Recent literature has suggested a dual pathway of ovarian serous carcinogenesis, with most serous carcinomas falling into 1 of 2 categories, low grade and high grade. These are considered to represent 2 distinct tumor types with a different underlying pathogenesis and associated with different molecular events, clinical behavior, and prognosis. Low-grade serous carcinoma is thought to evolve in many instances from a preexisting serous borderline tumor and cystadenoma. Given the distinct pathogenesis and different molecular events, it is expected that the coexistence of low-grade and high-grade serous carcinoma would be rare or may even be mutually exclusive; moreover, there are very few reported examples in the literature. We report a series of 7 cases in patients aged 34 to 78 years in whom ovarian low-grade serous carcinoma (4 cases, including 3 with associated serous borderline tumor), serous borderline tumor (2 cases), or seromucinous borderline tumor (1 case) was associated with a high-grade carcinoma, either high-grade serous (5 cases) or undifferentiated carcinoma (2 cases). The low-grade and high-grade components coexisted in the original neoplasm in 4 cases, and the high-grade component was present only in recurrence in 3 cases. In both instances, the undifferentiated carcinoma had a focal rhabdoid morphology, and alternative primary sites of tumor were excluded by a combination of clinical, radiologic, and pathologic parameters. We illustrate that low-grade serous carcinoma or serous borderline tumor (“low-grade” serous neoplasms) may rarely be associated with, and probably give rise to, a high-grade carcinoma, either high-grade serous or undifferentiated carcinoma. The coexistence of a low-grade serous neoplasm and undifferentiated carcinoma can be regarded as a form of dedifferentiation. p53 was diffusely positive in 4 of 6 high-grade carcinomas, which raises the possibility that secondary Tp53 mutation is important in high-grade transformation in some of these cases. WT1 was negative in the 2 undifferentiated carcinomas, and PAX8 was positive in 1, suggesting that the latter marker is more useful in helping to confirm a Mullerian origin in dedifferentiated low-grade serous neoplasms.Keywords
This publication has 32 references indexed in Scilit:
- Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesisPathology, 2011
- A Comprehensive Analysis of PAX8 Expression in Human Epithelial TumorsAmerican Journal of Surgical Pathology, 2011
- The biological and clinical value of p53 expression in pelvic high‐grade serous carcinomasThe Journal of Pathology, 2010
- Differences in Tumor Type in Low-stage Versus High-stage Ovarian CarcinomasInternational Journal of Gynecological Pathology, 2010
- Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovaryThe Journal of Pathology, 2010
- High‐grade serous carcinoma arising in a low‐grade serous carcinoma and micropapillary serous borderline tumour of the ovary in a 23‐year‐old womanHistopathology, 2009
- My approach to and thoughts on the typing of ovarian carcinomasJournal of Clinical Pathology, 2007
- Undifferentiated carcinoma of the endometrium: a reviewPathology, 2007
- Advances in the Recognition of Tubal Intraepithelial CarcinomaAdvances in Anatomic Pathology, 2006
- The Histologic Type and Stage Distribution of Ovarian Carcinomas of Surface Epithelial OriginInternational Journal of Gynecological Pathology, 2004